Andino v. Novo Nordisk A/S et al
Plaintiff: Alyssa Andino
Defendant: Novo Nordisk A/S, Novo Nordisk North America Operations A/S, Novo Nordisk US Holdings, Inc., Novo Nordisk US Commercial Holdings, Inc., Novo Nordisk, Inc., Novo Nordisk Research Center Seattle, Inc., Novo Nordisk Pharmaceutical Industries LP and Eli Lilly and Company
Case Number: 2:2023cv08868
Filed: December 1, 2023
Court: US District Court for the Eastern District of New York
Presiding Judge: Lee G Dunst
Nature of Suit: Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability
Cause of Action: 28 U.S.C. ยง 1332 Diversity-Product Liability
Jury Demanded By: Plaintiff
Docket Report

This docket was last retrieved on December 26, 2023. A more recent docket listing may be available from PACER.

Date Filed Document Text
December 26, 2023 Filing 8 NOTICE of Electronic Filings Entered In RE: GLUCAGON-LIKE PEPTIDE-I RECEPTOR AGONISTS (GLP-1 RAS) PRODUCTS LIABILITY LITIGATION, MDL No. 3094. (GO)
December 8, 2023 Filing 6 NOTICE from Counsel Morgan & Morgan to EDNY dated 12/4/2023 Re: Plaintiffs' Motion for Transfer of Actions to the United States District Court for the Western District of Louisiana, along with five (5) attachments and one (1) CD containing 36 exhibits, filed on December 1, 2023, in the above-referenced matter. (GO)
December 7, 2023 Filing 5 Summons Issued as to Eli Lilly and Company, Novo Nordisk A/S, Novo Nordisk North America Operations A/S, Novo Nordisk Pharmaceutical Industries LP, Novo Nordisk Research Center Seattle, Inc., Novo Nordisk US Commercial Holdings, Inc., Novo Nordisk US Holdings, Inc., Novo Nordisk, Inc. (AMF)
December 6, 2023 Filing 4 Proposed Summons. by Alyssa Andino (Anello, Virginia)
December 4, 2023 Filing 3 Clerks Notice Re: Consent. A magistrate judge has been assigned as the presiding judge in this case as part of a Pilot Program, governed by EDNY Administrative Order 2023-23. In accordance with Rule 73 of the Federal Rules of Civil Procedure, Local Rule 73.1, the parties are notified that if all parties consent, the assigned Magistrate Judge is available to conduct all proceedings in this action including a (jury or nonjury) trial and to order the entry of a final judgment. Attached to this Notice is a blank copy of the consent form that should be filled out, signed and filed electronically only if all parties wish to consent. The form is also available here: #https://www.nyed.uscourts.gov/edny-direct-assignment-pilot-program. Any party may withhold its consent without adverse substantive consequences. Do NOT return or file the consent unless all parties have signed the consent. Unless all parties consent to the Magistrate Judge jurisdiction by the deadline set forth in the Administrative Order 2023-23, a District Judge will be assigned to the case. The parties are directed to review the terms of Administrative Order 2023-23 and other materials related to the Pilot Program on the Courts website: #https://www.nyed.uscourts.gov/edny-direct-assignment-pilot-program. (LJ)
December 4, 2023 Filing 2 This attorney case opening filing has been checked for quality control. See the attachment for corrections that were made. (LJ)
December 4, 2023 Case Assigned to Magistrate Judge Lee G. Dunst. Please download and review the Individual Practices of the assigned Judges, located on our #website. Attorneys are responsible for providing courtesy copies to judges where their Individual Practices require such. (LJ)
December 4, 2023 Your proposed summons was not issued for the following reason: The full case caption must appear on the summons and/or the attached rider. Please correct and resubmit using the event Proposed Summons/Civil Cover Sheet. (LJ)
December 1, 2023 Filing 1 COMPLAINT against Eli Lilly and Company, Novo Nordisk A/S, Novo Nordisk North America Operations A/S, Novo Nordisk Pharmaceutical Industries LP, Novo Nordisk Research Center Seattle, Inc., Novo Nordisk US Commercial Holdings, Inc., Novo Nordisk US Holdings, Inc., Novo Nordisk, Inc. filing fee $ 405, receipt number ANYEDC-17338095 Was the Disclosure Statement on Civil Cover Sheet completed -NO,, filed by Alyssa Andino. (Attachments: #1 Civil Cover Sheet, #2 Proposed Summons) (Anello, Virginia)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the New York Eastern District Court's Electronic Court Filings (ECF) System

Search for this case: Andino v. Novo Nordisk A/S et al
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Alyssa Andino
Represented By: Virginia E Anello
Represented By: Michael A London
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Novo Nordisk A/S
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Novo Nordisk North America Operations A/S
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Novo Nordisk US Holdings, Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Novo Nordisk US Commercial Holdings, Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Novo Nordisk, Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Novo Nordisk Research Center Seattle, Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Novo Nordisk Pharmaceutical Industries LP
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Eli Lilly and Company
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?